Literature DB >> 1987535

Low-level lead exposure and children's cognitive function in the preschool years.

D Bellinger1, J Sloman, A Leviton, M Rabinowitz, H L Needleman, C Waternaux.   

Abstract

In a cohort of 170 middle and upper-middle class children participating in a prospective study of child development and low-level lead exposure, higher blood lead levels at age 24 months were associated with lower scores at age 57 months on the McCarthy Scales of Children's Abilities. The mean blood lead level at age 24 months was 6.8 micrograms/dL (SD = 6.3; 75th, 90th, and 99th percentiles: 8.8, 13.7, 23.6, respectively) and for all but 1 child was less than 25 micrograms/dL, the current definition of an "elevated" level. After adjustment for confounding, scores on the General Cognitive Index decreased approximately 3 points (SE = 1.4) for each natural log unit increase in 24-month blood lead level. The inverse association between lead level and performance was especially prominent for visual-spatial and visual-motor integration skills. Higher prenatal exposures were not associated with lower scores at 57 months except in the subgroup of children with "high" concurrent blood lead levels (ie, greater than or equal to 10 micrograms/dL). The concentration of lead in the dentine of shed deciduous teeth was not significantly associated with children's performance after adjustment for confounding.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987535

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  83 in total

1.  Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter.

Authors:  Richard L Canfield; Charles R Henderson; Deborah A Cory-Slechta; Christopher Cox; Todd A Jusko; Bruce P Lanphear
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

2.  Lead exposure and visual-motor abilities in children from Chennai, India.

Authors:  Kavitha Palaniappan; Ananya Roy; Kalpana Balakrishnan; Lakshmi Gopalakrishnan; Bhramar Mukherjee; Howard Hu; David C Bellinger
Journal:  Neurotoxicology       Date:  2011-04-08       Impact factor: 4.294

Review 3.  Developmental neuropathology of environmental agents.

Authors:  Lucio G Costa; Michael Aschner; Annabella Vitalone; Tore Syversen; Offie Porat Soldin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

4.  The public health implications of humans' natural levels of lead.

Authors:  D R Smith; A R Flegal
Journal:  Am J Public Health       Date:  1992-11       Impact factor: 9.308

5.  Developmental effects of exposure to environmental tobacco smoke and material hardship among inner-city children.

Authors:  V A Rauh; R M Whyatt; R Garfinkel; H Andrews; L Hoepner; A Reyes; D Diaz; D Camann; F P Perera
Journal:  Neurotoxicol Teratol       Date:  2004 May-Jun       Impact factor: 3.763

6.  Environmental lead exposure and children's cognitive function.

Authors:  R L Canfield; T A Jusko; K Kordas
Journal:  Riv Ital Pediatr       Date:  2005-12       Impact factor: 2.638

7.  Potential frameworks to support evaluation of mechanistic data for developmental neurotoxicity outcomes: A symposium report.

Authors:  Laura M Carlson; Frances A Champagne; Deborah A Cory-Slechta; Laura Dishaw; Elaine Faustman; William Mundy; Deborah Segal; Christina Sobin; Carol Starkey; Michele Taylor; Susan L Makris; Andrew Kraft
Journal:  Neurotoxicol Teratol       Date:  2020-02-14       Impact factor: 3.763

8.  The impact of psychosocial stressors on African-American and Latino preschoolers.

Authors:  J Tuakli-Williams; J Carrillo
Journal:  J Natl Med Assoc       Date:  1995-07       Impact factor: 1.798

Review 9.  Molecular targets of lead in brain neurotoxicity.

Authors:  Carla Marchetti
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

10.  Quercetin relieves chronic lead exposure-induced impairment of synaptic plasticity in rat dentate gyrus in vivo.

Authors:  Pu Hu; Ming Wang; Wei-Heng Chen; Ji Liu; Liang Chen; Shu-Ting Yin; Wu Yong; Ju-Tao Chen; Hui-Li Wang; Di-Yun Ruan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-05-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.